| Literature DB >> 21337807 |
E I Cortés-Gutiérrez1, M I Dávila-Rodríguez, J L Fernández, C López-Fernández, J Gosálvez.
Abstract
This study investigated possible variations in the chromatin structure of koilocytes resulting from human papillomavirus (HPV) infection. Alkaline-labile sites (ALS) were detected with the DNA breakage detection–fluorescence in situ hybridization (DBD-FISH) technique using a whole human genome DNA probe obtained from individuals without koilocytosis. The variable levels of ALS present were measured quantitatively using image analysis after whole-genome DNA hybridization. A significant increase in the number of ALS was observed in koilocytes compared with normal cells. We demonstrated that the presence of ALS could be an indicator of chromatin change in koilocytes caused by HPV infection.Entities:
Mesh:
Substances:
Year: 2010 PMID: 21337807 PMCID: PMC3167319 DOI: 10.4081/ejh.2010.e32
Source DB: PubMed Journal: Eur J Histochem ISSN: 1121-760X Impact factor: 3.188
Figure 1Papanicolaou-stained cervix epithelial cells showing propidium iodide (PI), DBD-FISH, and comet assay of normal cells, binucleate/multinucleate koilocyes, demonstrating the percentage of koilocytes (binucleate and multinucleate) in the Papanicolaou stain, the halo of hybridization in DBD-FISH, and a comet assay on one specimen with CIN 1.
Fluorescence analysis (area, intensity, ID, and mass/ID) of koilocytes (binucleate and multinucleate) and normal nuclei of cervical epithelial cells of women with CIN 1 after DBD-FISH.
| Fluorescence analysis | ||||
|---|---|---|---|---|
| Cell type | Area | Intensity | ID | CM/ID |
| (mean±SD) | (mean±SD) | (mean±SD) | (mean±SD) | |
| Normal | 2×103±3×103 | 78×103±77×103 | 3×108±7×108 | 1.5E5 |
| Koilocytes | ||||
| Binucleate | 18×103±7×103 | 864×103±639×103 | 173×108±123×108 | 9.6E5 |
| Multinucleate | 37×103±11×103 | 1645×103±1037×103 | 624×108±480×108 | 16E5 |
ID= integrated density (area × fluorescence intensity); CM= chromatin mass;
Different to control, P<0.05.
HPV genotyping in cytological specimens of women with CIN 1.
| HPV Genotypes | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Patient | 16 | 18 | 26 | 31 | 33 | 39 | 44 | 51 | 52 | 54 | 68 | 70 | 69–71 | 82 |
| A | X | X | X | X | X | X | X | |||||||
| B | X | X | X | X | X | X | X | |||||||
| C | X | |||||||||||||
| D | X | X | X | X | X | X | X | |||||||
| E | X | |||||||||||||
| Total | 2 | - | 3 | 3 | 3 | - | 3 | 1 | 3 | 3 | - | - | 2 | - |
HPV-high risk: 16, 18, 26*, 31, 33, 39, 51, 52, 82. HPV-low risk: 44, 54, 68, 69–71, 70.
Should be considered probably carcinogenic.[19]